Most linked-to pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #201 to #250.
- Chronic lymphatic leukemia (2 links)
- Chronic lymphocytic leukaemia (2 links)
- Chronic lymphocytic leukemia (2 links)
- Chronic spontaneous urticaria (2 links)
- Citatuzumab bogatox (2 links)
- Cixutumumab (2 links)
- Clazakizumab (2 links)
- Clenoliximab (2 links)
- Clivatuzumab tetraxetan (2 links)
- Clostridium difficile (bacteria) (2 links)
- Clostridium difficile colitis (2 links)
- Clumping factor A (2 links)
- Coagulation factor III (2 links)
- Coagulation factor IX (2 links)
- Coagulation factor X (2 links)
- Codrituzumab (2 links)
- Colony stimulating factor 1 receptor (2 links)
- Colony stimulating factor 2 (2 links)
- Colorectal cancer (2 links)
- Coltuximab ravtansine (2 links)
- Complement 5 (2 links)
- Complement C5 (2 links)
- Complement component 5 (2 links)
- Complement factor D (2 links)
- Conatumumab (2 links)
- Concizumab (2 links)
- Connective tissue growth factor (2 links)
- Crenezumab (2 links)
- Crohn's Disease (2 links)
- Crohn's disease (2 links)
- Crotedumab (2 links)
- Cytomegalovirus (2 links)
- DLL4 (2 links)
- Dabigatran (2 links)
- Dacetuzumab (2 links)
- Daclizumab (2 links)
- Dalotuzumab (2 links)
- Dapirolizumab pegol (2 links)
- Daratumumab (2 links)
- Dectrekumab (2 links)
- Delta-like ligand 3 (2 links)
- Demcizumab (2 links)
- Denintuzumab mafodotin (2 links)
- Denosumab (2 links)
- Depatuxizumab mafodotin (2 links)
- Dermatomyositis (2 links)
- Detumomab (2 links)
- Diabetes (2 links)
- Diabetes mellitus type 1 (2 links)
- Diabetic nephropathy (2 links)